Correlation between pre-operative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 8, 2008, Pages 1103-1110

  Donatelli, F ^a   Cavagna, P ^a   Di Dedda, G ^a   Catenacci, A ^a   Di Nicola, M ^a,b   Lorini, L ^a   Fumagalli, R ^c   Carli, F ^d  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cardiopulmonary bypass; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; INSULIN; MONOCOMPONENT INSULIN; PROPOFOL; REMIFENTANIL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTIVE SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; METABOLIC STRESS; METABOLIC SYNDROME X; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; THORACIC SURGERY;

EID: 49849106098     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01693.x     Document Type: Article

References (35)

1. Kuntschen FR, Galletti PM, Hahn C. Glucose-insulin interactions during cardiopulmonary bypass. Hypothermia versus normothermia. J Thorac Cardiovasc Surg 1986 91 : 451 9.
2. Kuntschen FR, Galletti PM, Hahn C et al. Alterations of insulin and glucose metabolism during cardiopulmonary bypass under normothermia. J Thorac Cardiovasc Surg 1985 89 : 97 106.
3. Lehot JJ, Piriz H, Villard J et al. Glucose homeostasis. Comparison between hypothermic and normothermic cardiopulmonary bypass. Chest 1992 102 : 106 11.
4. Anderson RE, Hansson LO, Liska J et al. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg 2000 69 : 847 50.
5. Chaney MA, Nikolov MP, Blakeman BP et al. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 1999 89 : 1091 5.
6. Rassias AJ, Givan AL, Marrin CA et al. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002 94 : 1113 9, table of contents.
7. Smith CE, Styn NR, Kalhan S et al. Intraoperative glucose control in diabetic and nondiabetic patients during cardiac surgery. J Cardiothorac Vasc Anesth 2005 19 : 201 8.
8. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001 345 : 1359 67.
9. Ouattara A, Lecomte P, Le Manach Y et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005 103 : 687 94.
10. Furnary AP, Zerr KJ, Grunkemeier GL et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999 67 : 352 60 discussion 60-2.
11. Lazar HL, Chipkin SR, Fitzgerald CA et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004 109 : 1497 502.
12. Gandhi GY, Nuttall GA, Abel MD et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007 146 : 233 43.
13. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000 83 (Suppl. 1) : S39 48.
14. Lidfeldt J, Nyberg P, Nerbrand C et al. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003 5 : 106 12.
15. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation. Diabetes Med 2006 23 : 469 80.
16. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 9.
17. Hanley AJ, Williams K, Stern MP et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002 25 : 1177 84.
18. Sekiguchi M, Kurabayashi M, Adachi H et al. Usefulness of insulin resistance measured by homeostasis model assessment in predicting restenosis after coronary stent placement in nondiabetic patients. Am J Cardiol 2004 93 : 920 2.
19. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000 23 : 57 63.
20. Emoto M, Nishizawa Y, Maekawa K et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999 22 : 818 22.
21. Bonora E, Zavaroni I, Alpi O et al. Insulin and C-peptide responses to 75 g oral glucose load in the healthy man. Diabetes Metab 1986 12 : 143 8.
22. Kerchner J, Colaluca DM, Juhl RP. Effect of whole blood on insulin adsorption onto intravenous infusion systems. Am J Hosp Pharm 1980 37 : 1323 5.
23. Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 106 : 3143 421.
24. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002 21 : 232 44.
25. Shann KG, Likosky DS, Murkin JM et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006 132 : 283 90.
26. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995 98 : 75 84.
27. de Rekeneire N, Peila R, Ding J et al. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 2006 29 : 1902 8.
28. Esposito K, Ciotola M, Marfella R et al. The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res 2005 17 : 224 6.
29. Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004 14 : 228 32.
30. van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006 354 : 449 61.
31. Donatelli F, Vavassori A, Bonfanti S et al. Epidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only. Anesth Analg 2007 104 : 1587 93, table of contents.
32. Prasad AA, Kline SM, Schuler HG et al. Clinical and laboratory correlates of excessive and persistent blood glucose elevation during cardiac surgery in nondiabetic patients: a retrospective study. J Cardiothorac Vasc Anesth 2007 21 : 843 6.
33. Myles PS, Hunt JO, Fletcher H et al. Remifentanil, fentanyl, and cardiac surgery: a double-blinded, randomized, controlled trial of costs and outcomes. Anesth Analg 2002 95 : 805 12, table of contents.
34. Steinlechner B, Dworschak M, Birkenberg B et al. Low-dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery: a dose-finding study. Br J Anaesth 2007 98 : 598 603.
35. Weale NK, Rogers CA, Cooper R et al. Effect of remifentanil infusion rate on stress response to the pre-bypass phase of paediatric cardiac surgery. Br J Anaesth 2004 92 : 187 94.